Biomarkers for late-onset neonatal sepsis

Genome Medicine

Volumn 2, Issue 9, 2010, Pages

  Polin, Richard A ^a   Randis, Tara M ^a  

^a NY Presbyterian Morgan Stanley Children's Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; APOLIPOPROTEIN C2; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID A; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

CRITICALLY ILL PATIENT; EARLY DIAGNOSIS; HOSPITAL INFECTION; HUMAN; LIPID METABOLISM; NECROTIZING ENTEROCOLITIS; NEWBORN SEPSIS; NOTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 78751690031     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm179     Document Type: Note

References (12)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole W. Sepsis in very low birth weight neonates; the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291. 10.1542/peds.110.2.285, 12165580.
2. Lottspeich F, Kellermann J, Keidel EM. Molecular biology tools: proteomics techniques in biomarker discovery. Scand J Clin Lab Invest Suppl 2010, 242:19-22. 10.3109/00365513.2010.493359, 20515271.
3. Ng PC, Ang IL, Chiu RWK, Li K, Lam S, Wong RPO, Chui KM, Cheung HM, Ng EWY, Fok TF, Sung JJY, Lo YMD, Poon TCW. Host response biomarkers for diagnosis of late onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest 2010, 120:2989-3000. 2912182, 20592468.
4. Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V, Coussieu C, Gauthier E, Courtine M, Zucker JD, Barsh GS, Saris W, Bruneval P, Basdevant A, Langin D, Clément K. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 2005, 48:519-528. 10.1007/s00125-004-1654-6, 15729583.
5. Yamada T, Miyake N, Itoh K, Igari J. Further characterization of serum amyloid A4 as a minor acute phase reactant and a possible nutritional marker. Clin Chem Lab Med 2001, 39:7-10. 10.1515/CCLM.2001.003, 11256804.
6. Iriyama K, Nishiwaki H, Terashima H, Tonouchi H, Miki C, Suzuki H, Carpentier YA. Apolipoprotein C-II modifications associated with an infusion of artificial lipid particles. JPEN J Parenter Enteral Nutr 1988, 12:60-62. 10.1177/014860718801200160, 3125357.
7. Murch O, Collin M, Hinds CJ, Thiemerman C. Lipoproteins in inflammation and sepsis. I. Basic Science. Intensive Care Med 2007, 33:13-24. 10.1007/s00134-006-0432-y, 17093985.
8. Samra JS, Summers KM, Frayn KN. Sepsis and fat metabolism. Br J Surg 1996, 83:1186-1196. 10.1002/bjs.1800830906, 8983604.
9. Liberatori A, Bini L, De Felice C, Magi B, Marzocchi B, Reggiaschi R, Pallini V, Bracci R. Acute phase proteins in perinatal plasma. Electrophoresis 1997, 18:520-526. 10.1002/elps.1150180331, 9150935.
10. Malle E, Sodin-Semri S, Kovacevic A. Serum amyloid A. An acute phase protein involved in tumor pathogenesis. Cell Mol Life Sci 2009, 66:9-26. 10.1007/s00018-008-8321-x, 18726069.
11. Arnon S, Litmanovitz I, Regev R, Bauer S, Lis M, Shainkin-Kestenbaum R, Dolfin T. Serum amyloid A protein is a useful inflammatory marker during late onset sepsis in preterm infants. Biol Neonate 2005, 87:105-110. 10.1159/000081979, 15539766.
12. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 2006, 368:1012-1021. 10.1016/S0140-6736(06)69342-2, 16980117.